We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$13.8B
AUM Growth
+$1.02B
Cap. Flow
+$618M
Cap. Flow %
4.47%
Top 10 Hldgs %
12.42%
Holding
2,126
New
119
Increased
1,428
Reduced
493
Closed
63

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.5M
2
WMT icon
Walmart Inc
WMT
+$16.8M
3
IBM icon
IBM
IBM
+$16.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$15.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$14.5M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$26.9M
2
DEG
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
+$14.8M
3
NJ
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
+$10.2M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.5M
5
ARMH
ARM HOLDINGS PLC ADS
ARMH
+$6.4M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 14.95%
3 Healthcare 13.94%
4 Consumer Staples 9.08%
5 Industrials 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
101
RenaissanceRe
RNR
$13.8B
$31.2M 0.23%
259,289
+24,159
+10% +$2.85M
CL icon
102
Colgate-Palmolive
CL
$74.8B
$30.7M 0.22%
413,429
+19,883
+5% +$1.47M
GIS icon
103
General Mills
GIS
$20.2B
$30.2M 0.22%
472,611
+10,994
+2% +$765K
TWX
104
DELISTED
Time Warner Inc
TWX
$30M 0.22%
376,495
+20,130
+6% +$1.57M
BIIB icon
105
Biogen
BIIB
$30.9B
$29.7M 0.21%
94,817
+5,454
+6% +$1.62M
AGN
106
DELISTED
Allergan plc
AGN
$29.6M 0.21%
128,664
+23,562
+22% +$5.76M
GM icon
107
General Motors
GM
$80.9B
$29.6M 0.21%
930,380
+59,185
+7% +$1.85M
KMB icon
108
Kimberly-Clark
KMB
$37.6B
$28.5M 0.21%
225,658
+6,349
+3% +$821K
SPG icon
109
Simon Property Group
SPG
$76.4B
$28.3M 0.2%
136,782
+6,528
+5% +$1.42M
SNY icon
110
Sanofi
SNY
$107B
$28.3M 0.2%
741,074
+23,772
+3% +$954K
BTI icon
111
British American Tobacco
BTI
$136B
$28.2M 0.2%
442,120
-2,506
-0.6% -$159K
AXP icon
112
American Express
AXP
$224B
$28M 0.2%
436,620
+20,059
+5% +$1.29M
GS icon
113
Goldman Sachs
GS
$289B
$27.1M 0.2%
168,140
+6,565
+4% +$1.07M
ABT icon
114
Abbott
ABT
$188B
$27M 0.2%
638,029
+101,414
+19% +$4.35M
AET
115
DELISTED
Aetna Inc
AET
$26.4M 0.19%
228,770
-3,991
-2% -$468K
CA
116
DELISTED
CA, Inc.
CA
$26.3M 0.19%
794,172
-44,677
-5% -$1.51M
DUK icon
117
Duke Energy
DUK
$101B
$26.2M 0.19%
326,980
+2,718
+0.8% +$225K
GSK icon
118
GSK
GSK
$107B
$25.8M 0.19%
478,082
+37,914
+9% +$2.08M
SAP icon
119
SAP
SAP
$215B
$25.2M 0.18%
276,217
+13,721
+5% +$1.18M
ELV icon
120
Elevance Health
ELV
$81.5B
$25.2M 0.18%
200,901
-17,339
-8% -$2.24M
BDX icon
121
Becton Dickinson
BDX
$46.4B
$25.1M 0.18%
143,377
+3,619
+3% +$619K
ADBE icon
122
Adobe
ADBE
$105B
$25.1M 0.18%
231,421
+12,297
+6% +$1.23M
SHPG
123
DELISTED
Shire pic
SHPG
$25M 0.18%
129,204
+3,712
+3% +$724K
VR
124
DELISTED
Validus Hold Ltd
VR
$25M 0.18%
502,716
+58,547
+13% +$2.91M
WBK
125
DELISTED
Westpac Banking Corporation
WBK
$25M 0.18%
1,101,381
+44,732
+4% +$1.02M
3 4
5
6 7

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2016 Portfolio in Review

As of Q3 2016, Aperio Group held 2,126 positions worth $13.8B, up 8% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $618M of net new capital in Q3 2016, opening 119 new positions and adding to 1,428 existing holdings. Its largest new stake was Fortive: 345,212 shares worth $11.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.5M trimmed.

  • Aperio Group's largest Q3 2016 buy was Fortive: 345,212 shares worth $11.1M.
  • Aperio Group added most to Apple in Q3 2016, an estimated $22.5M increase.
  • Aperio Group's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $8.5M.
  • Aperio Group fully exited EMC CORPORATION in Q3 2016, selling an estimated $26.9M.
  • Aperio Group's ten largest holdings make up 12% of its $13.8B portfolio in Q3 2016.
  • Aperio Group opened 119 new positions and closed 63 in Q3 2016.
  • Aperio Group's portfolio value rose 8% quarter-over-quarter to $13.8B.

Based on Aperio Group's 13F filing for Q3 2016, filed 2 Nov 2016.